Early and long-term outcomes of patients undergoing liver resection and diaphragm excision for advanced colorectal liver metastases

Annals of the Royal College of Surgeons of England

Volumn 91, Issue 6, 2009, Pages 483-488

  Lordax, Jeffrey T ^a   Riga, Angela ^a   Worthingtox, Tim R ^a   Karanjia, Nariman D ^a  

^a Royal Surrey Hospital   (United Kingdom)

Author keywords

Colorectal liver metastases; Diaphragm excision; Hepatectomy; Liver resection

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; DIAPHRAGM; FEMALE; HUMAN; LENGTH OF STAY; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; MUSCLE TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIAPHRAGM; FEMALE; HEPATECTOMY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 70350436493     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588409X432176     Document Type: Article

References (26)

1. McKay A, Dixon E, Taylor M. Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg 2006; 93: 1192-1201
2. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of the published studies. Br J Cancer 2006; 94: 982-999
3. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993; 71 (Suppl): 4252-4266
4. Rees M, Plant G. Bygrave S. Late results justify resection for multiple hepatic metastases from colorectal cancer. BrJ Surg 1997; 84: 1136-1140
5. Hurewitz H, Fehrenbacher L, Novotny W, Cartwright T. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342
6. Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P et al. Survival benefit of repeat liver resections for recurrent colorectal matastases: 143 cases. J Clin Oncol 1994; 12: 1491-1496
7. Elias D, Liberale G, Vernerey D, Pocard M, Ducreux M, Boige V et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005; 12: 900-909
8. Jamison RL, Donahue JH, Nagomey D. Hepatic resection for metastatic colorectal results in cure for some patients. Arch Surg 1997; 132: 505-510
9. Ueno H, Mochizuki H, Hashiguchi Y, Hatsuse K, Fujimoto H, Hase K. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 2004; 91: 327-333
10. Wei AC, Greig PD, Grant D, Taylor C, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 2006; 13: 668-676
11. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. IE. analysis and examples. Br J Cancer 1977; 35: 1-39.
12. Dimick JB, Pronovost PJ, Lipsett PA. Complications and cost after high risk surgery: where should we focus our quality improvement efforts? Crit Care Med 2001; 29 (Suppl): A161.
13. Kalish RL, Daley J, Duncan CC. Costs of potential complications of care for major surgery patients. Am J Med Qual 1995; 10: 48-54.
14. Stone ME, Rehman SU, Conaway G, Sardi A. Hepatic resection at a community hospital. J Gastrointestinal Surg 2000; 4: 349-353
15. Karanjia ND, Lordan JT, Fawcett WJ, Quiney N, Worthington TR. Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases - a ten year study. European Journal of Surgical Oncology 2008; Epub ahead of print.
16. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Valliant JC, Balladur P et al. (Association Franchise de Chirurgie). Long-term survivaE following resection of colorectal hepatic metastases. Br J Surg 1997; 84: 977-980
17. Kemeny MM, Adak S, Gray B., Maccionald JS, Smith T, Lipsitz S eta!. Combined-modality treatment for respectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy. J Clin Oncol 2002; 20: 1499-1505
18. Poston GJ, Corkhill AK, Finch-Jones M, Mirza D, Parks RW, Davidson B etal. Perioperative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer: final efficacy results of the EPOC intergroup randomized phase III study (EORTC 40983). Br J Surg 2007; 94 (SuppB 5): 6.
19. Scheele J, Altendorf-Hofmann A, Grube T. Resection of colorectal liver metastases. What prognostic factors determine patient selection? Chirurg2001; 72: 547-560
20. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016
21. Esquivel J, Elias D, Baratti D. Kusamura S, Deraco M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008; 98: 263-267
22. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab pius irinotecan in ihnotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351: 337-345
23. Giantonio BJ, Levy DE, O'Dwyer PJ, Meropol NJ, Catalano PJ, Benson AB. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol 2006; 17: 1399-1403
24. Hochester HS. Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer. Semln Oncol 2006; 33: S8-14.
25. Hofheinz RD, Horisberger K, Woernle C, Wenz F, Kraus-Tiefenbacher U, Kahler G et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radlat Oncol Biol Phys 2006; 68: 1384-1390
26. Saif MW, Kang SP, Chu E. Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies. Oncology 2006; 20: 11-19